The UK’s private healthcare sector is experiencing unprecedented growth as the National Health Service (NHS) grapples with soaring waiting lists and stretched public resources. With elective treatment queues in England exceeding 7.4 million patients, private healthcare is increasingly seen as a necessary alternative for timely care.
The ongoing impact of the COVID-19 pandemic, coupled with long-standing administrative challenges, has exacerbated pressures on NHS services. In response, private healthcare providers have expanded rapidly, supported by a rising number of individuals purchasing private insurance and companies implementing employee health plans.
Legal Industry Benefits from Healthcare Boom
The surge in private healthcare demand is generating considerable legal activity. Traditionally, deal-making lawyers have dominated law firm workloads, but the current climate has shifted their focus toward healthcare-related mergers, acquisitions, and private equity transactions.
Health Secretary Wes Streeting’s appeal to the private sector to assist with long NHS waiting lists has opened the door for private investment. Lawyers specializing in complex healthcare transactions are thriving, particularly those with expertise in mergers and acquisitions (M&A), private equity, and life sciences.
Private Equity Investment Reaches Record Levels
According to PwC data, private equity involvement in the UK healthcare sector reached record highs in 2024, with 57% of deals in 2023 involving PE backing—a significant increase compared to other industries. PE investment in healthcare has grown nearly 20% since 2018, reflecting strong investor confidence in the sector’s long-term potential.
Private equity firms are actively acquiring established and start-up healthcare enterprises, aiming to scale operations, integrate advanced technologies, and meet rising patient demands. This activity spans hospitals, care homes, fertility clinics, and technology-driven healthcare solutions such as AI and robotics.
Expansion in Care Homes, Fertility, and Advanced Healthcare
The private healthcare sector’s growth is also driven by demographic shifts, including an ageing population with increasingly complex health needs. Recent acquisitions illustrate the trend: Mysa Care, backed by Downing, acquired the Partnership of Care, a provider operating 41 care homes, while FutureLife, a PE-backed European group, acquired the Bristol Centre for Reproductive Medicine to expand its IVF and genetics services in the UK.
These transactions highlight both consolidation within existing companies and targeted expansions into specialized healthcare areas. The sector’s robust growth suggests continued M&A activity, with particular focus on hospitals, care technology, IVF, and pharmaceuticals.
Financial Pressures on Patients and Families
The rising demand for private healthcare has placed financial pressures on many patients. A notable number of Britons are turning to family support—often referred to as the ‘Bank of Mum and Dad’—to access treatments not readily available through the NHS.
Private equity partners emphasize that investment is not only driven by NHS shortcomings but also by structural factors, including an ageing population and ongoing technological innovation, which make private healthcare a resilient and expanding market.
Related topics
